GSK in deal to produce Israeli nutritional growth formula to children
JERUSALEM, Sept 28 (Reuters) -
* GlaxosmithKline Consumer Healthcare has entered into a licence agreement with Israel's Nutritional Growth Solutions (NG Solutions) for Horlicks Growth+, a formula aimed at boosting height and weight in short and thin children aged 3 to 9, NG said on Wednesday.
* GSK will produce and market Horlicks, which was developed at Israel's Schneider Children's Medical Centre.
* NG did not disclose financial details, citing confidentiality, but said the agreement includes upfront payment and royalties.
* The formula, which consists of high protein and contains vitamins and minerals, was launched in India by GSK in May. (Reporting by Steven Scheer)